Jon Cheigh
About Jon Cheigh
Jon Cheigh, 52, is President and Chief Investment Officer of Cohen & Steers (CNS). He joined CNS in 2005 as a REIT analyst, became a portfolio manager in 2008, was appointed CIO in 2019, and was named President effective January 1, 2025. He holds a BA cum laude from Williams College and an MBA from the University of Chicago . Company performance under the current leadership included 2024 revenues of $517.4M (+5.7% YoY), operating margin of 33.4% (35.4% as adjusted), and diluted EPS of $2.97 ($2.93 as adjusted), alongside strong investment results (95% of portfolios beat benchmarks on 1-year; 96–99% over 3/5/10 years) and a 2024 TSR index value of 175.38 (base $100) .
Company performance snapshot
| Metric | 2023 | 2024 |
|---|---|---|
| Revenues ($M) | 489.6 | 517.4 |
| Operating Margin (%) | 33.6 (36.2 as adjusted) | 33.4 (35.4 as adjusted) |
| Diluted EPS ($) | 2.60 (2.84 as adjusted) | 2.97 (2.93 as adjusted) |
| TSR Index (start $100) | 139.71 | 175.38 |
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Cohen & Steers | President and Chief Investment Officer | 2025–present | Leads investment department and executive leadership agenda . |
| Cohen & Steers | Chief Investment Officer | 2019–2024 | Senior PM for global real estate; strengthened processes and culture . |
| Cohen & Steers | Head of Global Real Estate | 2012–2023 | Advanced listed and private real estate strategies . |
| Cohen & Steers | Portfolio Manager | 2008–present | Senior PM for all global real estate strategies . |
| Cohen & Steers | REIT Analyst | 2005–2008 | Coverage and research underpinning real assets platform . |
| Security Capital Research & Management | VP, Senior REIT Analyst | pre-2005 | Buy-side REIT research expertise . |
| InterPark | VP, Real Estate Acquisitions | pre-2005 | Direct real estate transaction experience . |
| Urban Growth Property Trust | Acquisitions Associate | pre-2005 | Private real estate acquisitions experience . |
Fixed Compensation
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Base Salary ($) | 375,000 | 375,000 | 375,000 |
| Target Bonus (%) | Not disclosed | Not disclosed | Not disclosed |
| Cash Bonus Paid ($) | 3,345,000 | 2,865,000 | 3,345,000 |
| All Other Compensation ($) | 170,113 (incl. 401k match; dividend equivalents) | 189,186 (incl. 401k match; dividend equivalents) | 199,035 (incl. 401k match; dividend equivalents) |
Notes:
- CNS uses discretionary, holistic assessments rather than formulaic targets or weightings for annual incentives .
- Executives receive standard employee benefits (401k with match; ESPP) and are prohibited from hedging CNS stock .
Performance Compensation
| Component | Year | Structure | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|---|---|
| Annual performance incentives (cash) | 2022 | Discretionary, based on financial, investment, strategic objectives | Not disclosed | Not disclosed | Not disclosed | $3,345,000 | N/A |
| Annual performance incentives (cash) | 2023 | Discretionary | Not disclosed | Not disclosed | Not disclosed | $2,865,000 | N/A |
| Annual performance incentives (cash) | 2024 | Discretionary | Not disclosed | Not disclosed | Not disclosed | $3,345,000 | N/A |
| Mandatory RSU deferral (part of annual incentives) | 2022 | RSUs in lieu of cash; deferral % at committee discretion | Not disclosed | N/A | N/A | $2,480,000 | Ratably over 4 years; dividends accrue as RSUs vesting on last tranche |
| Mandatory RSU deferral | 2023 | Same as above | Not disclosed | N/A | N/A | $2,160,000 | 4-year ratable; dividends accrue |
| Mandatory RSU deferral | 2024 | Same as above | Not disclosed | N/A | N/A | $2,480,000 | 4-year ratable; dividends accrue |
| RSU grant for 2023 performance | Granted 1/31/2024 | 30,127 RSUs; grant-date FV $2,159,955 | N/A | N/A | N/A | N/A | Vests ratably last business day of Jan 2025–2028; dividends accrue and vest on last date |
Additional points:
- For 2024, the Committee increased Cheigh’s total compensation by 14.8% vs. 2023; 94.0% of his 2024 total comp was performance incentives, with 40% deferred in RSUs .
- CNS does not currently grant stock options or similar awards .
Equity Ownership & Alignment
- Beneficial ownership (as of March 6, 2025): 86,835 shares of common stock; RSUs held: 80,910; ownership <1% of outstanding .
- Unvested RSUs at FY-end (12/31/2024): 85,903 units (includes 7,675 unvested dividend equivalents), market value $7,932,283 at $92.34/share .
- Ownership guidelines: CNS does not maintain formal stock ownership guidelines for executives given significant insider ownership; hedging of CNS securities is prohibited .
| Ownership detail | As of | Value/Count |
|---|---|---|
| Beneficially owned shares | 03/06/2025 | 86,835 shares (<1%) |
| RSUs held (non-voting) | 03/06/2025 | 80,910 units |
| Unvested RSUs (market value) | 12/31/2024 | 85,903 units; $7,932,283 value @ $92.34 |
Alignment and pledging:
- No disclosure of any pledged Cheigh shares; company policy prohibits hedging; insider trading governed by policy with preclearance/blackouts .
Employment Terms
- Agreements: No separate employment agreement for Cheigh disclosed; incentive awards governed by CNS Amended & Restated Stock Incentive Plan .
- Change-in-control (CIC): Double-trigger accelerated vesting of unvested RSUs if terminated without cause or resigns for good reason within 2 years post-CIC; also accelerates upon death or disability .
- Potential payout proxy values (as of 12/31/2024): Accelerated RSU vesting of $7,932,283 upon qualifying CIC termination or death/disability (based on $92.34/share) .
| Scenario (as of 12/31/2024) | Estimated value |
|---|---|
| Termination without cause or resignation for good reason within 2 years post-CIC | $7,932,283 (accelerated RSUs) |
| Death or disability | $7,932,283 (accelerated RSUs) |
Key definitions: “Cause,” “Good Reason,” “Change in Control,” and “Disability” are defined in award agreements as summarized in the proxy .
Insider Trading and Vesting/Selling Pressure
Recent Form 4 activity indicates periodic sales around vesting cycles:
- 05/22/2024: Sold 7,159 shares at $72.57; proceeds ≈ $519,529 .
- 07/25/2024: Sold 12,500 shares at $84.08; proceeds ≈ $1,050,988 .
- 05/09/2025: Sold 25,500 shares at $80.01; proceeds ≈ $2,040,255 .
Additional RSU accruals:
- Dividend equivalent RSUs periodically accrue on unvested RSUs (e.g., 2025Q2 accruals reported for executives) and vest with the final tranche, supporting ongoing supply near vest dates .
Implication: Mandatory 4-year ratable vesting on late-January schedules (plus mid-year accruals) creates repeatable windows for potential insider liquidity; however, Cheigh retains a substantial position and continues to receive deferred equity, aligning longer-term incentives .
Performance & Track Record
- 2024 impact: Delivered strong investment performance relative to benchmarks; advanced listed and private real estate strategies; strengthened processes and succession planning; partnered on corporate strategy and growth initiatives .
- 2023 impact: Demonstrated leadership; improved select strategy performance; progressed succession and hiring plans; advanced listed/private real estate processes .
- Say-on-Pay support: 93.55% approval in most recent vote, signaling shareholder support for pay practices .
- Pay vs performance linkage: Company discloses “compensation actually paid” and TSR peers; 2024 TSR index at 175.38 vs peer group 257.30; Operating Income (as adjusted) used as company-selected measure .
Compensation Structure Analysis
- Mix and deferral: High proportion of at-risk, performance-linked compensation; significant mandatory equity deferral for senior executives enhances retention and alignment (Cheigh: 94% of 2024 comp was performance incentives; 40% deferred) .
- No options; time-vested RSUs: CNS does not grant options; RSUs vest over four years with dividend equivalents accruing; no PSU framework disclosed (reduces performance-risk asymmetry but strengthens retention) .
- Discretionary framework: No preset weightings/targets; Committee balances investment results, financial outcomes (including “as adjusted” metrics), strategic progress, talent and culture .
Multi-Year Compensation (Committee view; performance-year basis)
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Base Salary ($) | 375,000 | 375,000 | 375,000 |
| Cash Bonus ($) | 3,345,000 | 2,865,000 | 3,345,000 |
| Mandatory RSU Deferral ($) | 2,480,000 | 2,160,000 | 2,480,000 |
| Total ($) | 6,200,000 | 5,400,000 | 6,200,000 |
Note: SEC Summary Compensation Table differs in timing (reports grant-date FV when granted); the table above ties compensation to performance year, consistent with committee discussion .
Equity Grants and Outstanding Awards
| Detail | Value |
|---|---|
| 2024 RSU grant for 2023 performance | 30,127 RSUs; $2,159,955 grant-date FV (granted 1/31/2024) |
| Vesting schedule | Ratable on last business day of Jan 2025–2028; dividend equivalents accrue and vest at final tranche |
| Unvested RSUs at FY-end 2024 | 85,903 RSUs (incl. 7,675 dividend equivalents), market value $7,932,283 @ $92.34 |
Governance and Policies Relevant to Incentives
- Clawback: NYSE/Rule 10D-1 compliant recoupment policy; mandatory recovery of erroneously awarded incentive-based compensation after restatements on a no-fault basis .
- Hedging/short sales: Prohibited for directors and employees .
- Ownership guidelines: No formal guidelines; rationale is high insider ownership; founders control significant stakes (context for governance; not specific to Cheigh) .
Investment Implications
- Alignment: High share of at-risk pay and multi-year RSU vesting tie Cheigh’s outcomes to long-term investment and financial performance; no options or PSUs reduces performance-leverage but strengthens retention via time-based equity .
- Liquidity windows: Mandatory deferral and January vesting create recurring supply; observed 2024–2025 insider sales suggest potential near-term selling pressure around vesting, though Cheigh maintains sizable holdings and ongoing equity accruals .
- Retention and succession: 2024 Committee commentary highlights succession execution and talent pipeline; equity deferrals support retention in the investment franchise .
- CIC risk/reward: Double-trigger RSU acceleration yields meaningful value in a change-in-control termination, aligning incentives in strategic events while avoiding single-trigger windfalls .
- Shareholder posture: Strong Say-on-Pay support (93.55%) indicates investor acceptance of the discretionary, equity-heavy design, though absence of formal ownership guidelines is atypical among peers .